Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

olpadronate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
BACKGROUND Periodontitis is characterized by gingival inflammation, periodontal pocket formation, and bacterial plaque that lead… Expand
Highly Cited
2004
Highly Cited
2004
BACKGROUND Non-randomised studies have suggested beneficial effects of bisphosphonates in osteogenesis imperfecta. We assessed… Expand
Highly Cited
2002
Highly Cited
2002
Bisphosphonates (BPs) are pyrophosphate analogues in which the oxygen in P-O-P has been replaced by a carbon, resulting in a… Expand
Highly Cited
1999
Highly Cited
1999
Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1999
Highly Cited
1999
Bisphosphonates (Bps), inhibitors of osteoclastic bone resorption, are used in the treatment of skeletal disorders. Recent… Expand
Highly Cited
1999
Highly Cited
1999
Bisphosphonates, synthetic compounds used in the treatment of skeletal disorders, suppress osteoclast‐mediated bone resorption by… Expand
Highly Cited
1998
Highly Cited
1998
Prostate cancer is predominantly associated with osteoblastic bone metastases, but an increase in bone resorption has been… Expand
Review
1997
Review
1997
&NA; Abbreviations used in this article: 25‐OHD, 25‐hydroxy vitamin D; 1,25‐DHD, 1,25‐dihydroxy vitamin D; BMD, bone mineral… Expand
Highly Cited
1997
Highly Cited
1997
Abstract Osteoporosis is an important feature of osteogenesis imperfecta (OI). So far, no effective medical treatment is… Expand
  • table 1
  • figure 1
  • figure 2
Highly Cited
1996
Highly Cited
1996
Bisphosphonates are used with increasing frequency in the management of skeletal complications in patients with breast cancer. In… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 6